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ABSTRACT 
Developing a temperature-sensidve plasmid to create 
Bruce/la knockout mutants. (April 2004) 
Midhat Saleem Farooqi 
Department of Biochemistry & Biophysics 
Texas A&M University 
Fellows Advisor: Dr. Thomas A. Ficht 
Department of Veterinary Pathobiology 
Gene knockouts in an organism give valuable information about that gene's 
function. The current method for producing Bruce!la knockout mutants — sacB insertion 
followed by sucrose counterselecdon — is inefficient. A novel procedure for generating 
unmarked Bruce/la knockouts is proposed. First, the target gene is replaced by an 
antibiotic resistance marker via homologous recombination. Then, this marker is excised 
by flippase, an enzyme encoded by a temperature-sensitive plasmid. The plasmid is 
subsequently removed from Bruce/la by raising the temperature. 
To obtain such a temperature-sensitive mutant, the broad-host-range plasmid 
pBBRl was mutated using the E. col/ strain, XL1-Red. Mutation of the plasmid DNA 
was verified by blue/white screening. Afterwards, the mutants were screened for 
temperature-sensitivity by replica plating and growth at the permissive (30'C) and non- 
permissive (42'C) temperatures. A total of 2, 400 colonies were screened, and two 
temperature-sensitive plasmids were isolated. However, further analysis by replica 
plating showed that the two plasmids were temperature-sensitive for antibiotic 
resistance, not replication. 
These plasmids cannot be removed from Brucella by raising the temperature. 
Hence, it is not yet clear whether the proposed method can generate knockout mutants of 
Bruce/la. Future studies should mutate pBBR1 more extensively, or apply the 
mutagenesis procedure to a different plasmid, such as pGL10. 
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I. INTRODUCTION 
Brucellosis: Disease & Treatment 
Brucellosis is an infectious disease that primarily affects animals, most 
frequently cows and goats . However, humans can become infected as well if they drink i 
unpasteurized milk contaminated with the bacteria, or handle an infected animal. Hence, 
brucellosis, like rabies, is a zoonosis. In animals, the disease results in abortion, orchitis, 
and sterility. Hmnans, however, experience a range of less severe symptoms: headaches, 
undulant fever, and loss of appetite. Any combination of these can persist for three to 
twelve months and recur afterwards. 
Bacteria classified in the genus Brucella cause this disease. Though all of these 
organisms are gram-negative, facultative, and non-motile, different species. of Brucella 
cause brucellosis in different animals . Cows, for example, are susceptible to Brucella 
abortus, while goats succumb to Brucella ntelitenris. Some other species include B. suis 
and B. canis which infect pigs and dogs, respectively. All four of these species can cause 
disease in humans. However, B. melitensis is the most virulent and responsible for the 
majority of severe cases of human brucellosis . 3 
Once inside the body, Brucella penetrates the mucosa and triggers a natural 
inunune response . Macrophages and neutrophils residing in the submucosa ingest the 4 
bacterium through phagocytosis. These immune cells, however, are unable to destroy 
Brucella. The pathogen somehow evades the killing mechanisms of these phagocytes 
and proliferates within them. Bacteremia develops within 1-3 weeks of exposure, after 
which Brucella localizes to organs rich in reticuloendothelial tissue — e. g. , the lymph 
nodes, spleen, and liver . If left untreated, brucellosis can be fatal . 
Serological agglutination tests are widely used to diagnose brucellosis in both 
animals and humans . Human brucellosis patients are treated with combinations of 6 
antibiotics such as rifampin and doxycycline. Unfortunately, a human vaccine for 
brucellosis does not exist today. For animals, however, three vaccines are available: 
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B. abornis S19, B. aborrus RB51, and B. melirensis REV. I. The first two are used to 
immunize cattle, while the latter protects goats and sheep. Neither type meets the current 
standards for safety and efficiency that apply to human vaccines'. 
Nonetheless, a human vaccine for brucellosis needs to be developed. One reason 
why is because there is growing concern that microorganisms, such as Bnicega, will 
mutate to gain antibiotic resistance. This event would render the current treatment for the 
disease ineffective. Also, since the pathogen survives well in aerosols and resists drying, 
it may be used as a biological weapon'. Actually, American researchers attempted to 
develop Brucella into a biological weapon in 1942 and, in fact, succeeded'. In 1954, it 
became the first bioweapon ever made, and, one year later, the United States was 
producing cluster bombs filled with B. suis. For these reasons, the Centers for Disease 
Control and Prevention recently classified Bvucella as a select agent . This fact alone 
highlights the need for a human vaccine for brucellosis. 
To have thc greatest chance of success, such a vaccine must be designed, not 
isolated by chance. It must be developed based on an understanding of how Brucella 
causes disease. However, the basis of B77ncega' s virulence has long defied description . 7 
The only well-defined virulence factor is the 0-antigen of the lipopolysaccharide coat. 
Otherwise, Brucella lacks the virulence factors — such as toxins and fimbria — commonly 
found in other pathogens. The recent release of Brucega's genomic sequence verified the 
absence of such virulence factors . Interestingly, genes controlling the survival and l0 
persistence of Brucega are the main features of its genome. 
Thercforc, one may assume that the pathogenesis of Bruce(la depends upon its 
ability to survive inside the host. Brucella, of course, initially resides in the host's white 
blood cells . These macrophages use low pH and reactive oxygen intermediates to break 
down the organisms they engulf. Brucega avoids this degradation by transcribing heat 
shock and other stress response genes. It is hypothesized that Brucella mutants produced 
from knocking out these genes will have reduced virulence and make good vaccine 
candidates. 
Candidate Knockout Genes 
The specific genes of interest in this study are: a~s24, dnaK ~aa J, and htrA. The 
expression of a~s24, for example, is optimal at pH values below 4. 0' '. This directly 
correlates with a period of bacterial survival in the acidic environment of macrophages. 
Thus, the gene is thought to be responsible for BruceIla resisting intracellular 
elimination within macrophages. The expression of dnaK is also increased in response to 
acid pH, which leads to higher levels of the molecular chaperone protein, DnaK. 
Without this protein, Brucella sids cannot replicate inside macrophages . Transcription 
of 
~aa J is increased in B. melitensis in response to heat shock . AapJ is a periplasmic 13 
protein that is involved in amino acid binding. Presumably, it helps Brucella adjust to the 
host cell's ainino acid pool. Another gene that is upregulated due to heat shock is htrA. 
The latter produces a serine protease that helps Brucella abortus resist destruction from 
phagocytes' . The genes selected are summarized below in Table I. 
Table J. Candidate knockout genes. 
Gene Protein Size (kDa) Function f3 pregul ation 
AapJ 
Asp24 
DnaK 
HtrA 
37. I 
20. 4 
68. 7 
60 
Amino acid binding 
Calcium binding 
Chaperone 
Protcasc 
Heat Shock 
Acid pH 
Acid pH 
I leat Shock 
Gene Knockout Methods in Brucella 
It is incredibly difficult to create Brucella knockout mutants using the current 
procedures available. One must first replace the gene of interest with an antibiotic 
resistance marker through homologous recombination and then remove this cassette. The 
deletion of the marker gene is crucial. Otherwise, not only has one introduced foreign 
DNA into the pathogen, but conferred antibiotic resistance to it as well. This is not 
suitable if one hopes to test these mutants as vaccine candidates. 
There are two techniques available to remove this antibiotic marker. In the first 
[5 
niethod, one replaces the marker with sacB, a gene that confers sucrose intolerance 
The bacteria are then grown on a medium containing sucrose, an environment that 
promotes the spontaneous loss of sacB. Bacteria that have lost the gene are easy to 
identify — they grow on the sucrose-containing medium. The second technique involves 
using a plasmid-encoded enzyme — flippase — to excise the antibiotic resistance gene". 
Both methods have drawbacks. Rather than being lost, the sacB gene may mutate 
and become inactivated. In this case, the bacterium would appear to be sucrose-resistant 
— and, so, an unmarked knockout — when, in truth, it would still contain sacB. 
Furthermore, the sacB method is inefficient: one study analyzed 200 colonies only to 
find 2 unmarked knockouts". 
In contrast, flippase removes the kanamycin marker at high frequencies — near 
100'/o". Unfortunately, the plasmid used to introduce flippase into Bruce//u remains 
inside thc bacterium after the excision. Thus, one still I'aces thc problem of foreign. DNA 
and antibiotic resistance — as encoded by the plasmid — in thc Bruce/la knockouts. 
Fortunately, this obstacle can be overcome if one uses a tcinperature-sensitive 
plasmid. Such a plasmid is stable at low temperatures (- 30'C) but very unstable at 
higher temperatures (- 42'C)'". This characteristic provides an easy way to remove the 
plasmid froin Bruce//ac grow the bacteria at a high tempcraturc. In these conditions, the 
plasmid is unstable and will be lost from the cell. 
This study proposes to use this novel flippase/temperature-sensitive plasmid 
procedure to create Bruce/la knockout mutants. The first step, then, is to create a 
temperature-sensitive plasmid. 
II. MUTAGENESIS Sc SCREENING OF PLASMID DNA 
Introduction 
To make a plasmid temperatwe-sensitive, one must first mutate the plasmid's 
DNA. There are many different mutagens one can use to accomplish this — e. g. , 
ultraviolet light, a chemical such as hydroxylamine, or PCR, to name a few. However, 
some of these mutagens are more effective than others at generating temperature- 
sensitive mutations, 
Previous work in the lab had shown that mutagenesis with ultraviolet light did 
not consistently mutate plasmid DNA (Farooqi, 2002, unpublished data). Thus, a 
different mutagen was desired. A literature search revealed that hydroxylamine had been 
used to produce a temperature-sensitive plasmid . Unfortunately, this chemical is very 19 
hazardous', making it difficult for an undergraduate student to use it openly in the lab. 
In addition, treatment of DNA with hydroxylamine would require subsequent dialysis- 
a highly laborious and expensive procedure. 
A safer and simpler method for mutating DNA was sought. It was found in the E. 
co/i strain XLI-Red . This cell line is deficient in three primary DNA repair genes— 21 
mutS, mutD, and mutT — prompting its mutation rate to be approximately 5, 000-fold 
higher than normal. Furthermore, it has been used to generate temperature-sensitive 
plasmids and alleles ' . Thus, XL1-Red was selected to mutate plasmid DNA. 
Materials k. Methods 
~Mt t. Th h d. h t d Pl tdPBBR1 t 1 d' t XLt-Rd 
cells (Stratagene, La Jolla, CA) following the manufacturer's instructions '. The plasmid 
pUC18 was used as a positive control and transformed in parallel. The transformants 
were grown on LB plates containing 30 12g/mL of chloramphenicol (Cm30) for 3 days 
at 37'C. Of the resulting colonies, two hundred were picked into 10 mL LB/Cm30 
broth and grown at 37 C for an additional four days. The plasmid was recovered from 
the XLI-Red ceffs via a mimi-prep (Sigma, St. Louis, MO) on the fourth, fiAh, sixth, and 
final day of mutagenesis. Agarose gel electrophoresis was used to verify that the DNA 
recovered was, indeed, that of pBBR I. Plasmid DNA isolated on the seventh day was 
used for the rest of this experiment. 
Blue/White Colon Screen. To ensure that the plasmid had been mutated, a blue-white 
colony screen was performed. Both the stock plasmid and the mutated plasmid were 
transformed into the chemically competent E. coli strain, Top10 (Invitrogen, Carlsbad, 
CA). The transformants werc plated on LB/Cm@30 plates, on which 32 (tL of X-Gal 
had been spread. 
Scrcenin for Tem erature-Sensitivi . The mutated plasmid DNA was then 
transformed into XL1-Blue — a supercompetent E. coli strain (Stratagene, La Jolla, CA) 
— and plated on LB/Cmga'30 plates. The colonies were then screened for temperature- 
sensitivity. 
Individual bacterial colonies were picked into 96-wel( dishes at one colony pcr 
well. Each well held 200 trL LB/Cm@30 broth. One dish was then stamped onto four 
LB/Cmgc&30 plates: the first 48 wells on two plates, and the remaining 48 wells on two 
other plates. One plate in each pair was placed at the permissive temperature (30'C) and 
thc other at the non-permissive temperature (42'C). 
Results 
Figurc 1 shows that the plasmid recovered after the mutagenesis was indccd pBBR1. 
Figure 1. Plasmid DNA as analyzed by gel electrophoresis. Lane I contams stock 
pBBRI DNA. Lanes 2-5 contain plasmid DNA recovered from XLI-Red cells via 
miniprep on days 4, 5, 6, and 7. 
The results of the blue/white colony screen are given in Table 2. The normal 
stock of plasmid contained no mutations. However, after growth in XLI-Red, mutations 
were seen in the plasmid's lacZ gene, which gave rise to white colonies. 
Table 2. Blue-White colony count. 
Plasmid Blue Colonies White Colonies Total % White 
PBBRI Stock 
pBBRI Mutated 264 46 310 14. 84 
151 0. 00 
Approximately 240 colonies were assessed before two candidates for 
temperature-sensitivity — designated A10 and C12 — were found. Another candidate, A2, 
was found after screening an additional 140 colonies. Figure 2 shows two of the three 
candidates. 
These three colonies were plated once more to confirm temperature-sensitivity. 
Figure 3 shows that two of three colonies — A2 and AIO — are indeed temperature- 
sensitive while C12 is not. However, AIO shows very poor growth at 30'C and no 
growth at 42'C. In contrast, A2 shows a much stronger phenotype by growing well at 
30'C but not growing at all when moved to 42'C. 
Figure 2. Two temperature-sensitive colony candidates. The plate on the left was grown 
at 30'C, while the one on the right was grown at 42'C. The 4 colony in the I" row 
(termed Al 0) and the last colony in the third row (termed C12) show a temperature- 
sensitive phenotype. 
Figure 3. Spot check of temperature-sensitive candidates. The plate on the left was 
grown at 30'C, while the one on the right was grown at 42'C. The top left quadrant 
contains colony C12. The lett spot is a control; it holds bacteria that grow equally well at 
both temperatures. The right spot consists of bacteria from well C12 of the 96-well 
culture dish. The top right quadrant contains colony A10. Again, the left spot is a 
control, and the right spot contains the colony being tested. The bottom left quadrant is 
colony A2. In this case, the right spot is the control. Colonies A2 and A10 were 
confirmed to be temperature-sensitive. 
III. CHARACTERIZATION OF THE MUTANT PLASMIDS 
Introduction 
Of course, there are two different mutations that could give rise to such a 
temperature-sensitive phenotype. One possibility is that the mutation occurs in the 
plasmid's replication gene (~Re ). The other is that it occurs in the plasmid*s antibiotic 
resistance gene (CmR). In the first case, the plasmid is unable to replicate at 42'C 
(Ts ). As a result, bacterial cells produced after replication no longer contain copies of sup 
the plasmid. These bacteria, then, cannot grow in the presence of the antibiotic. In the 
second case, the plasmid makes an antibiotic resistance protein that is functional at 30'C, 
but not at 42'C (Ts ). Here, the bacterium retains the plasmid, but is still unable to 
grow in the presence of the antibiotic. However, if the antibiotic is removed, both the 
plasmid and the bacterium are able to replicate at 42'C. 
Materials & Methods 
To distinguish between these two possibilities, colonies A2 and A10 were grown 
at 42'C on an antibiotic-free LB agar plate. This plate was then replica-plated onto an 
I. B/Cm@30 plate, and it was grown at 30'C. If the plasmid was Ts, it would be lost 
from the bacterium as it grew at 42'C (the first step). Therefore, this bacterium would be 
unable to grow at 30'C in the presence of chloramphenicol (the second step). However, 
if the plasmid was Ts, it would remain inside the bacterium as it grew at 42'C. This 
bacterium would still grow in the presence of chloramphenicol at 30'C. This method of 
differentiation is summarized in Figure 4. 
a) 
Plate C' 42 C 
No Antibiotic 
Plate C 30'C 
With Antibiotic 
No Growth 
b) Plasmid is lost 
Figure 4. Differentiating between a ts plasmid (a) and a ts plasmid (b). 
Results 
When carried out, the procedure showed that the two plasmids were temperature- 
sensitive for chloramphenicol resistance. The final replica plate is shown in Figure 5. 
Figure 5. Replica plate (30'C, LB/Cmo30) of the 42'C, no chloramphenicol plate. 
Following this result, an additional 960 colonies of bacteria were screened for 
temperature-sensitivity. There were no positive findings. This prompted the addition of 
another step in the procedure. 
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IV. ENRICHMENT OF PLASMID DNA 
Introduction 
A search of the literature revealed a procedure termed 'enrichment. ' Bernard 
Davis, a scientist who wanted to isolate biochemically deficient bacteria, developed this 
method". Bacteria that can grow only in the presence of a certain nutrient, such as 
histidine, are an example of the type of cells Dr. Davis wished to isolate. 
In this case, mutant bacteria (His cells) and normal bacteria (His' cells) can both 
grow in a culture containing histidine. However, if no histidine is present, only His+ cells 
can replicate. If one takes such a culture — one where only normal cells are dividing— 
and adds an antibiotic that specifically kills growing cells (like penicillin), then there 
will be a marked decrease in the concentration of His cells. As a result, the frequency of 
His cells in the culture will become much greater relative to His cells. 
This principle was applied to the case of temperature-sensitive bacteria. At 42'C, 
only bacteria containing normal plasmids will grow. Cells containing a temperature- 
scnsitive plasmid will remain dormant. The addition of a bacteriostatic antibiotic at this 
point should enrich for cells with a temperature-sensitive plasmid. 
Materials & Methods 
The mutated plasmid was transformed into XLI-Blue cells according to the 
manufacturer's instructions. 500 IiL of the transformation culture were used to inoculate 
50 mL of LB/Cm@30 broth. The culture was aerated overnight at 30'C and 250 rpm. 
500 ItL from the overnight culture were used to inoculate 10 mL of LB/Cm@30 broth. 
This culture was grown at 42'C, 250 rpm, until the optical density (at 550 nm) increased 
4 to 5-fold (approximately 2. 5 hours). At this point, ampicillin was added to give a final 
concentration of 40 Itg/mL. Then, the culture was aerated at 42'C, 250 rpm, once more 
until the ODsss decreased (approximately 30 minutes). Afterwards, the cells were 
recovered via centrifugation at 12, 000 rpm for 10 minutes. The bacteria were washed 
12 
twice with 1XPBS and then resuspended in LB/Cm@30 broth. Finally, the enrichment 
method was repeated to increase the efficiency of the procedure. 
Results 
The 'enriched' colonies were plated on LB/Cm@30 plates and screened for 
temperature-sensitivity as previously described. Not one colony out of the 864 assessed 
showed the desired phenotype. The lack of a positive result prompted a revision of the 
experimental procedure. 
V. REVISED EXPERIMENTAL PROCEDURE 
Introduction 
Previously, the plasmid DNA was mutated using XL1-Red cells following to the 
manufacturers' instructions. These directions called for the transformants to be grown at 
37'C. This poses a problem since this temperature may select against the generation of 
temperature-sensitive mutations. However, it should be noted that the scientists who 
used XL1-Red to make a temperature-sensitive plasmid grew the bacterial cells at 37'C 
following the manufacturer's directions". Nevertheless, to ensure that no selection 
against temperature-sensitive mutations occurred, the temperature was reduced to 30'C. 
Another cause for concern is that the enrichment procedure has never been 
applied to temperature-sensitive cells, much less plasmids. The method should work 
with temperature-sensitive bacteria, since these cells would probably remain dormant at 
42'C. However, the case of a temperature-sensitive plasmid is quite different. Rather 
than remain dormant, a normal bacterium containing a temperature-sensitive plasmid 
would probably lose the plasmid when grown at 42'C. Since it is the plasmid that is 
temperature-sensitive, the enrichment procedure may actually force the host cell to lose 
it. Again, to prevent any selection against a temperature-sensitive plasmid, the 
enrichment step was removed from the experiment. 
Materials & Methods 
The transformation ol'pBBR1 into XL1-Red cells was carried out as before, 
except all remaining steps after the 'heat shock' were carried out at 30'C. Again, the 
plasmid pUC18 was used as a positive control and transformed in parallek The 
transformants were grown on LB/Cm@30 plates for 9 days at 30'C. The mutated 
plasmid was recovered from the XL1-Red cells on the 9 day by a miniprep. 
To see how effectively the plasmid was mutated, a blue/white screening was 
performed using both pBBR1 and pUC18 (the positive control). Both the stock plasmid 
and mutant plasmid were transformed into Top10 cells. The transformants were plated 
on LB/Cm@30 plates — LB/Amp100 plates for the pUC18 transformants — containing 
32 ltL of X-Gak 
Afterwards, the pBBRl transformants were screened for temperature-sensitivity 
as previously described. 
Results 
Table 3 presents the colony count of the blue/white colony screen. The normal 
stock of plasmid contained no mutations. However, after growth in XL1-Red, both 
pBBR1 and pUC18 contained mutations — proven by the presence of white colonies. 
Table 3. Blue/White screening. 
Plasmid Blue Colonies White Colonies Total '/o White 
pBBR1 Stock 
pBBR1 Mutated 
pUC18 Mutated 
172 
146 
61 
25 
71 
172 
171 
132 
0. 00 
14. 62 
53. 79 
A total of 384 colonies were screened, and no temperature-sensitive candidates 
were found. 
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Vl. CONCLUSIONS AND FUTILE WORK 
A novel method of creating Brucella knockout mutants was proposed. It involved 
using a plasmid-encoded enzyme, flippase, to precisely excise a DNA cassette. It also 
called for a temperature-sensitive plasmid, because the latter could subsequently be 
removed from Brucella. This method offered several advantages over the current 
knockout procedure. First, it could be applied to a wide variety of genes. Second, 
knockouts would be produced at a much higher frequency relative to the sacB procedure. 
And finally, the knockout mutants would contain no gene markers, allowing the mutants 
to be used to develop a human vaccine for brucellosis. 
Unfortunately, the creation of a temperature-sensitive plasmid proved to be 
incredibly laborious and difficult. This was unexpected. One possible explanation is that 
temperature-sensitive mutations occurred in the plasmid's replication protein but were 
masked. Such an event would occur if the plasmid forsook its own protein and used the 
host cell's replicai. ion protein. However, pBIIRI is a broad-host range plasmid, which 
means that ii. depends very liti. le on the host cell for replication. Thus, such a masking 
event is very unlikely. 
Another way temperature-sensitive mutations could be masked is if there were 
multiple plasmids in one cell. In this scenario, the mutant plasmid is lost from the cell at 
42'C, but any normal plasmid present allows the bacterial cell to survive. To reduce this 
possibility, the plasmid was removed from XLI-Red cells and then retransformed into 
second bacterial strain. This approach has previously been used to reduce the problem of 
multiple plasmids in cells' . 
A more likely explanation as to why it was so difficult to find a temperature- 
sensitive plasmid is that pBBRI may not have been mutated very efficiently. As shown 
in Table 3, a mutant lacZ gene was found in pBBRI at a Irequency ol 14. 6'r'0. 
Comparatively, a lacZ mutation was much more frequent in pUCI 8 (nearly 53. 8'ro). Of 
course, pUC18 is smaller in size relative to pBBRI (2686 bp and 4707 bp, respectively). 
The former is also a high-copy plasmid, as opposed to pBBRI, which is low-copy. These 
qualities may explain the large difference between mutational rates of the two plasmids. 
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Another factor may be that pBBRI replication is more precise, making the plasmid less 
apt to mutate. Perhaps a different plasmid, such as pGL 1 0, should be used instead. 
In any case, further studies should use blue/v;hite screening as a tool to measure 
the effectiveness of the mutagenesis procedure, not only as a control. A target mutational 
frequency should be set, and pBBR1 should remain in XL I-Red cells until that goal is 
reached. A mutation rate of 14. 6'lo might be too low since only I out of 7 plasmids will 
contain a mutation in the target gene. Such a rate greatly 'reduces' the actual number of 
colonies screened. For example, one may assess 1, 000 colonies, but, at a mutational rate 
of 14. 6'fo, the effective number of colonies screened would be 143. 
Still, two temperature-sensitive plasmids were isolated through this 
procedure. Plus, two other studies have also been able to generate temperature-sensitive 
mutations. Perhaps this study was sound and all it lacked was the little bit of serendipity 
that accompanies every successful scientific study. 
What other methods besides mutagenesis can one use to make a temperature- 
sensitive plasmid? Well, one may clone a temperature-sensitive origin/protein into 
pBBRI from a known temperature-sensitive plasmid, such as pSC101". However, this 
would probably cause pBBRI to lose its broad-host range. Plus, a BLAST search of the 
pBBRI origin and replication protein found no homology to any known temperature- 
scnsitive plasmids. Consequently, such an approach is probably not worth pursuing. 
As for producing knockout mutants, one might just forego the temperature- 
sensitivc plasmid method altogether and usc sacB/sucrose counterselection method, 
instead. Again, this is less efficient than thc 11ippase inethod, and the possibility that 
sacB may mutate remains. But, one can verify loss of sacB by DNA sequencing or a 
Southern blot, and circumvent this problem. 
In spite of this, a temperature-sensitive plasmid operable in Bruce/la would still 
be a valuable research tool to scientists, since it would allow for a more efficient method 
of producing knockout mutants. It is regrettable that time, luck, and unanticipated 
problems prevented the development of a temperature-sensitive plasmid in this study. REP 
However, this work lays a strong foundation for future progress in this regard. 
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